Global Pediatric Drugs and Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others), By Drug Indication (Infectious Disease, Cancer, Allergy and Respiratory, Nervous System Disorders, Cardiovascular Disease, Diabetes, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Industry: Healthcare
RELEASE DATE Mar 2024
REPORT ID SI4094
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Technology
      2. Market Attractiveness Analysis By Drug Indication
      3. Market Attractiveness Analysis By Distribution Channel
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising pediatric population with growing prevalence of infectious diseases
      2. Rising awareness about the children’s healthcare needs
    3. Restraints
      1.  Lack of accessibility due to lack of awareness and inadequate healthcare infrastructure
    4. Opportunities
      1.  Rising occurrence of infectious diseases in children encourages raising spending on R&D for the development of pediatric medication.
    5. Challenges
      1. Decreasing the number of vaccinations due to affordability issues for low-income parents
  6. Global Pediatric Drugs and Vaccines Market Analysis and Projection, By Technology
    1. Segment Overview
    2. Live Attenuated
    3. Inactivated
    4. Subunit
    5. Toxoid
    6. Conjugate
    7. Others
  7. Global Pediatric Drugs and Vaccines Market Analysis and Projection, By Drug Indication
    1. Segment Overview
    2. Infectious Disease
    3. Cancer
    4. Allergy and Respiratory
    5. Nervous System Disorders
    6. Cardiovascular Disease
    7. Diabetes
    8. Others
  8. Global Pediatric Drugs and Vaccines Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Hospital Pharmacies
    3. Retail Pharmacies
    4. Online Pharmacies
  9. Global Pediatric Drugs and Vaccines Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Pediatric Drugs and Vaccines Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Pediatric Drugs and Vaccines Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   AstraZeneca 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Sanofi 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   GlaxoSmithKline plc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Pfizer 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Merck & Co. Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Novo Nordisk A/S
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Eli Lilly and Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Serum Institute of India Pvt. Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Panacea Biotec. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Merck Sharp & Dohme Corp.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Mitsubishi Tanabe Pharma Corporation
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Zydus Cadila 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Indian Immunologicals Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  2. Global Live Attenuated, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  3. Global Inactivated, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  4. Global Subunit, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  5. Global Toxoid, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  6. Global Conjugate, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  7. Global Others, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  8. Global Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  9. Global Infectious Disease, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  10. Global Cancer, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  11. Global Allergy and Respiratory, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  12. Global Nervous System Disorders, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  13. Global Cardiovascular Disease, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  14. Global Diabetes, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  15. Global Others, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  16. Global Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  17. Global Hospital Pharmacies, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  18. Global Retail Pharmacies, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  19. Global Online Pharmacies, Pediatric Drugs and Vaccines Market, By Region, 2023-2033(USD Billion)
  20. North America Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  21. North America Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  22. North America Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  23. U.S.  Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  24. U.S.  Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  25. U.S.  Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  26. Canada Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  27. Canada Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  28. Canada Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  29. Mexico Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  30. Mexico Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  31. Mexico Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  32. Europe Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  33. Europe Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  34. Europe Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  35. Germany Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  36. Germany Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  37. Germany Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  38. France Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  39. France Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  40. France Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  41. U.K.  Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  42. U.K.  Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  43. U.K.  Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  44. Italy Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  45. Italy Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  46. Italy Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  47. Spain Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  48. Spain Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  49. Spain Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  50. Asia Pacific Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  51. Asia Pacific Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  52. Asia Pacific Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  53. Japan Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  54. Japan Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  55. Japan Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  56. China Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  57. China Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  58. China Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  59. India Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  60. India Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  61. India Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  62. South America Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  63. South America Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  64. South America Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  65. Brazil Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  66. Brazil Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  67. Brazil Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  68. The Middle East and Africa Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD   Billion)
  69. The Middle East and Africa Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD   Billion)
  70. The Middle East and Africa Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  71. UAE Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  72. UAE Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  73. UAE Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)
  74. South Africa Pediatric Drugs and Vaccines Market, By Technology, 2023-2033(USD Billion)
  75. South Africa Pediatric Drugs and Vaccines Market, By Drug Indication, 2023-2033(USD Billion)
  76. South Africa Pediatric Drugs and Vaccines Market, By Distribution Channel, 2023-2033(USD Billion)

List of Figures 

  1. Global Pediatric Drugs and Vaccines Market Segmentation
  2. Pediatric Drugs and Vaccines Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Pediatric Drugs and Vaccines Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Pediatric Drugs and Vaccines Market
  20. Pediatric Drugs and Vaccines Market Segmentation, By Technology
  21. Pediatric Drugs and Vaccines Market For Live Attenuated, By Region, 2023-2033 ($ Billion)
  22.  Pediatric Drugs and Vaccines Market For Inactivated, By Region, 2023-2033 ($ Billion)
  23. Pediatric Drugs and Vaccines Market For Subunit, By Region, 2023-2033 ($ Billion)
  24. Pediatric Drugs and Vaccines Market For Toxoid, By Region, 2023-2033 ($ Billion)
  25. Pediatric Drugs and Vaccines Market For Conjugate, By Region, 2023-2033 ($ Billion)
  26. Pediatric Drugs and Vaccines Market For Others, By Region, 2023-2033 ($ Billion)
  27.  Pediatric Drugs and Vaccines Market Segmentation, By Drug Indication
  28.  Pediatric Drugs and Vaccines Market For Infectious Disease, By Region, 2023-2033 ($ Billion)
  29.  Pediatric Drugs and Vaccines Market For Cancer, By Region, 2023-2033 ($ Billion)
  30. Pediatric Drugs and Vaccines Market For Allergy and Respiratory, By Region, 2023-2033 ($ Billion)
  31. Pediatric Drugs and Vaccines Market For Nervous System Disorders, By Region, 2023-2033 ($ Billion)
  32. Pediatric Drugs and Vaccines Market For Cardiovascular Disease, By Region, 2023-2033 ($ Billion)
  33. Pediatric Drugs and Vaccines Market For Diabetes, By Region, 2023-2033 ($ Billion)
  34. Pediatric Drugs and Vaccines Market For Others, By Region, 2023-2033 ($ Billion)
  35. Pediatric Drugs and Vaccines Market Segmentation, By Distribution Channel
  36. Pediatric Drugs and Vaccines Market For Hospital Pharmacies, By Region, 2023-2033 ($ Billion)
  37. Pediatric Drugs and Vaccines Market For Retail Pharmacies, By Region, 2023-2033 ($ Billion)
  38. Pediatric Drugs and Vaccines Market For Online Pharmacies, By Region, 2023-2033 ($ Billion)
  39. Novartis AG: Net Sales, 2023-2033 ($ Billion)
  40. Novartis AG: Revenue Share, By Segment, 2023 (%)
  41. Novartis AG: Revenue Share, By Region, 2023 (%)
  42. AstraZeneca: Net Sales, 2023-2033 ($ Billion)
  43. AstraZeneca: Revenue Share, By Segment, 2023 (%)
  44. AstraZeneca: Revenue Share, By Region, 2023 (%)
  45. Sanofi: Net Sales, 2023-2033 ($ Billion)
  46. Sanofi: Revenue Share, By Segment, 2023 (%)
  47. Sanofi: Revenue Share, By Region, 2023 (%)
  48. GlaxoSmithKline plc.: Net Sales, 2023-2033 ($ Billion)
  49. GlaxoSmithKline plc.: Revenue Share, By Segment, 2023 (%)
  50. GlaxoSmithKline plc.: Revenue Share, By Region, 2023 (%)
  51. Pfizer: Net Sales, 2023-2033 ($ Billion)
  52. Pfizer: Revenue Share, By Segment, 2023 (%)
  53. Pfizer: Revenue Share, By Region, 2023 (%)
  54. Merck & Co. Inc.: Net Sales, 2023-2033 ($ Billion)
  55. Merck & Co. Inc.: Revenue Share, By Segment, 2023 (%)
  56. Merck & Co. Inc.: Revenue Share, By Region, 2023 (%)
  57. Novo Nordisk A/S: Net Sales, 2023-2033 ($ Billion)
  58. Novo Nordisk A/S: Revenue Share, By Segment, 2023 (%)
  59. Novo Nordisk A/S: Revenue Share, By Region, 2023 (%)
  60. Eli Lilly and Company: Net Sales, 2023-2033 ($ Billion)
  61. Eli Lilly and Company: Revenue Share, By Segment, 2023 (%)
  62. Eli Lilly and Company: Revenue Share, By Region, 2023 (%)
  63. Serum Institute of India Pvt. Ltd..: Net Sales, 2023-2033 ($ Billion)
  64. Serum Institute of India Pvt. Ltd..: Revenue Share, By Segment, 2023 (%)
  65. Serum Institute of India Pvt. Ltd..: Revenue Share, By Region, 2023 (%)
  66. Panacea Biotec.: Net Sales, 2023-2033 ($ Billion)
  67. Panacea Biotec.: Revenue Share, By Segment, 2023 (%)
  68. Panacea Biotec.: Revenue Share, By Region, 2023 (%)
  69. Merck Sharp & Dohme Corp.: Net Sales, 2023-2033 ($ Billion)
  70. Merck Sharp & Dohme Corp.: Revenue Share, By Segment, 2023 (%)
  71. Merck Sharp & Dohme Corp.: Revenue Share, By Region, 2023 (%)
  72. Mitsubishi Tanabe Pharma Corporation: Net Sales, 2023-2033 ($ Billion)
  73. Mitsubishi Tanabe Pharma Corporation: Revenue Share, By Segment, 2023 (%)
  74. Mitsubishi Tanabe Pharma Corporation: Revenue Share, By Region, 2023 (%)
  75. Zydus Cadila: Net Sales, 2023-2033 ($ Billion)
  76. Zydus Cadila: Revenue Share, By Segment, 2023 (%)
  77. Zydus Cadila: Revenue Share, By Region, 2023 (%)
  78. Indian Immunologicals Ltd.: Net Sales, 2023-2033 ($ Billion)
  79. Indian Immunologicals Ltd.: Revenue Share, By Segment, 2023 (%)
  80. Indian Immunologicals Ltd.: Revenue Share, By Region, 2023 (%)
  81. Others: Net Sales, 2023-2033 ($ Billion)
  82. Others: Revenue Share, By Segment, 2023 (%)
  83. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:8.04%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies